A raised ALT, GGT or another liver marker on an executive blood test is a finding to interpret, not a diagnosis to guess from a colour-coded report. The pattern of results, previous measurements, medicines, metabolic health and symptoms help a doctor decide what needs investigating and how quickly. A modest change can deserve attention, while a single raised marker does not tell the whole story.
The Wellness offers doctor-led blood testing and results review in London. A useful review gives you an explanation and an organised next step, whether that is further blood testing, an ultrasound, a fibrosis assessment or specialist advice. The purpose is to understand the cause and protect your health, with each investigation answering a defined clinical question.
Arrange a doctor-led review of your liver blood tests
Why liver blood tests are not a single liver-health score
The familiar phrase "liver function tests", or LFTs, groups together measurements that provide different information. Some reflect liver-cell injury or problems involving bile flow. Others can help assess the liver's ability to make proteins or process substances. A doctor interprets them together rather than assigning a diagnosis from one number.
The British Society of Gastroenterology guideline on abnormal liver blood tests explains this distinction. ALT and related enzymes do not, by themselves, measure how well the liver performs every function. Bilirubin, albumin, clotting tests and the wider blood count may add different information, depending on the clinical question.
That is why an extensive biomarker report still needs a clinical review. The significance of a result depends on which marker is affected, the degree and pattern of change, your history and whether the finding is new. A laboratory reference range helps identify a result for attention; it does not replace the assessment.
ALT, AST, ALP and GGT: what the pattern can tell a doctor
ALT and AST are enzymes used when assessing possible liver-cell injury. They are not specific diagnoses. A raised result may lead to questions about metabolic health, alcohol, medication, infection and other conditions. The doctor also considers whether another source or a recent event could be relevant.
ALP and GGT can help assess a pattern involving the liver and bile ducts. ALP can also come from bone, so an isolated ALP rise needs interpretation rather than an assumption that it means liver disease. GGT can provide context, but it cannot establish an alcohol-related cause on its own.
Bilirubin is interpreted alongside the rest of the panel and symptoms. Some patterns have a different explanation from others, and jaundice needs medical assessment. Albumin can add information about liver synthetic function, but a low albumin also has causes outside the liver. The benefit of the review is connecting these measurements rather than treating each flag as a separate condition.
A mild rise still deserves a reasoned explanation
The size of an abnormality is not a reliable measure of how serious its cause is. The BSG guideline recommends reviewing abnormal results with previous tests, medical history and current health. It also advises considering investigation for an underlying cause irrespective of the level and duration of the abnormality.
This does not mean every small rise requires an urgent scan or an identical panel. It means that repeating the same tests without considering the cause is not a complete plan. The doctor should explain whether a repeat is checking a likely temporary change, whether investigation is needed now, and what would alter that decision.
For someone managing a demanding diary, clarity is useful. You should leave knowing which result matters, what the next step is intended to answer and when someone will review it. A reassuring explanation should be based on the assessment, not simply on the fact that the result is only just outside the range.
Discuss raised ALT, GGT or other liver markers with The Wellness
Metabolic fatty liver: why normal enzymes do not settle the question
Fat can build up in the liver in association with metabolic factors. The current name is metabolic dysfunction-associated steatotic liver disease, or MASLD. You may still see the older term non-alcoholic fatty liver disease, or NAFLD, on reports and patient information. NICE renamed its guidance in July 2026 to reflect the newer terminology.
The NHS explanation of fatty liver disease describes links with factors including overweight, type 2 diabetes, high blood pressure and high cholesterol. The condition often causes no symptoms and may be found during testing for another reason. A result should therefore be considered alongside metabolic risk, rather than only how you feel.
Normal routine liver blood tests do not rule out MASLD or significant fibrosis. Conversely, an abnormal ALT is not enough to establish MASLD. The clinician considers other causes and whether imaging or further assessment is appropriate. The purpose is to understand both the likely diagnosis and whether there is evidence of more advanced damage.
Executive screening is most useful here when it joins up the picture. Glucose regulation, blood pressure, lipids, weight history and liver assessment can inform a coherent plan. Adding more biomarkers without explaining what they change is less useful than selecting investigations that lead to a decision.
What fibrosis testing adds
Fibrosis means scarring. Tests intended to assess fibrosis answer a different question from a routine ALT or GGT measurement. A person can have liver fat without advanced scarring, and the distinction helps guide care and referral.
Depending on the clinical pathway, the doctor may use a blood-based score such as FIB-4 or consider another test, such as the enhanced liver fibrosis blood test or liver-stiffness measurement. These methods have different uses and limitations. They are not interchangeable with a diagnosis from a standard liver panel.
The BSG guideline describes staged assessment in relevant adults, with first-line risk assessment followed by further tests where indicated. Age and clinical circumstances affect interpretation. A score should not be read as a universal pass-or-fail result, and a low score does not explain every persistent abnormality.
Your doctor can explain why a particular test is being recommended, how the result will affect the plan and whether a specialist should review it. This article does not suggest that every executive assessment includes elastography, an ELF test or imaging. The appropriate investigation and its arrangements should be confirmed for the individual.
Alcohol, medicines and supplements: a full history matters
An accurate alcohol history helps the doctor assess possible causes and give useful advice. A raised GGT alone cannot prove that alcohol is responsible, and an assumption based on one result can distract from another condition. The discussion should be clinical and practical, without judgement.
Prescribed medicines, over-the-counter products, herbal remedies and sports or wellness supplements also belong in the review. Provide names, doses and when you started them. A product described as natural still needs to be considered when a liver result changes.
Do not stop prescribed treatment on the basis of a highlighted result without medical advice. The doctor should weigh the medicine's benefits, the pattern of results and the likelihood of a treatment-related cause. Where a change is needed, the plan should explain what replaces it or how the underlying condition will be managed.
What further investigation may involve
The BSG guideline describes a standard adult liver aetiology screen that can include ultrasound, viral hepatitis tests, selected antibodies and immunoglobulins, and ferritin with transferrin saturation. This is an investigation of possible causes, not a recommendation to order every test independently.
Your history and examination help determine the appropriate pathway. A previously established diagnosis, a new symptom or a particular pattern on the panel can change the sequence and urgency. The doctor may need additional information before recommending a scan or referral.
A useful private review also brings together testing already done elsewhere. Original laboratory reports, previous scans and the dates of treatment changes can help avoid repeating investigations unnecessarily. Where a report leaves uncertainty, the review should name it and explain how the next step will address it.
Request a doctor-led executive biomarker review in London
When not to wait for a routine screening review
New jaundice, meaning yellowing of the skin or the whites of the eyes, requires urgent medical advice. Significant abdominal pain, marked illness or other concerning new symptoms also need assessment rather than a routine screening enquiry. The urgency depends on the symptoms and the whole clinical picture.
Severe confusion, vomiting blood, black tarry stools or serious deterioration require emergency help. The NHS cirrhosis guidance sets out emergency warning signs in people with established cirrhosis. An executive blood-testing appointment is not a substitute for urgent care. Once the immediate issue has been assessed, planned follow-up can be organised around the findings.
Most laboratory flags are not an emergency in isolation, but the report cannot make that judgement without context. If the testing service or a clinician has already given you an urgent instruction, follow it rather than waiting for another routine appointment.
A practical plan after executive blood testing
The review should distinguish three things: what is known, what still needs explaining and what happens next. That may include a targeted investigation, support for metabolic health, a medicine review or specialist advice. Any repeat test should have a reason and a named clinician or team to consider the result.
Our corporate executive screening guide sets out the wider assessment context. This liver-marker review addresses the next stage: turning a result into appropriate clinical care. It also fits with an organised follow-up plan after executive screening, while allowing earlier assessment whenever needed.
The Wellness can help arrange a doctor-led review of your results and discuss appropriate next steps. The appointment scope, fee and any additional investigations should be confirmed before booking. The value is a medical explanation with continuity, not a promise that a large panel can detect every condition or prevent every future illness.
Frequently asked questions
Does a raised ALT mean I have fatty liver?
No. ALT can be raised for several reasons. A doctor considers the complete panel, previous results, medicines, alcohol, metabolic risk and other possible causes. Further testing or imaging may be recommended to establish the explanation.
Can liver blood tests be normal when fatty liver is present?
Yes. Normal routine liver blood tests do not exclude MASLD or significant fibrosis. Assessment depends on the wider clinical picture and may include other investigations when appropriate.
Is GGT a reliable test of how much alcohol I drink?
GGT cannot establish an alcohol-related cause on its own. It must be considered with the other results and a clinical history. An accurate account of alcohol intake helps the doctor assess risk without assuming that every rise has the same explanation.
Should a slightly raised liver test just be repeated?
Sometimes a repeat is appropriate, but it should have a clinical purpose. BSG guidance recommends considering the cause and clinical context, because the size of an abnormality does not reliably show its significance. The doctor should explain whether investigation is needed alongside or instead of a repeat.
What is the difference between an ALT test and fibrosis testing?
ALT is an enzyme used in assessing possible liver-cell injury. Fibrosis assessment is concerned with scarring and the risk of more advanced liver disease. Blood-based scores and other tests may help in the appropriate pathway, but need clinical interpretation.
Can The Wellness review a liver panel from another provider?
You can request a doctor-led review and provide the original report, dates, previous investigations and medication history. The team confirms the scope and fee before booking. Further tests or specialist advice may be recommended if the existing information does not settle the clinical question.
Contact The Wellness about your liver blood test results
Evidence and further reading
- British Society of Gastroenterology: management of abnormal liver blood tests.
- NICE NG49: MASLD assessment and management, updated terminology July 2026.
- NHS: fatty liver disease, including MASLD.
This article provides general information for adults. It does not diagnose a condition or replace an individual medical assessment.